Evidence map›Paper›PMID 29785003›Full record

ArticleNature reviews. Gastroenterology & hepatology2018

Publisher Correction: The gut-liver axis and the intersection with the microbiome.

Anupriya Tripathi, Justine Debelius, David A Brenner, Michael Karin, Rohit Loomba, Bernd Schnabl, Rob Knight

Abstract readPublished Erratum
In one paragraph

Article in Nature reviews. Gastroenterology & hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Frontiers in pharmacology · 2021
    Article
  15. Pb Toxicity on Gut Physiology and Microbiota.Frontiers in physiology · 2021
    Review
  16. Review
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Anupriya TripathiDivision of Biological Sciences, University of California, San Diego, La Jolla, CA, USA.
Justine DebeliusDepartment of Pediatrics, University of California, San Diego, CA, USA.
David A BrennerNAFLD Research Center, Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, USA.
Michael KarinDepartment of Pediatrics, University of California, San Diego, CA, USA.
Rohit LoombaNAFLD Research Center, Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, USA.
Bernd SchnablDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Rob KnightDepartment of Pediatrics, University of California, San Diego, CA, USA. robknight@ucsd.edu.ORCID http://orcid.org/0000-0002-0975-9019

Funding

Yeast Genetics and Stress Response Genes-BiomedicalP42ES010337 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TUKEY, ROBERT H · 2000 to 2022
$69.8M
The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8M
REGULATION OF NFKB AND IKK BY PROINFLAMMATORY STIMULIR01AI043477 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KARIN, MICHAEL · 1998 to 2017
$7.4M
Role of Inflammation in tumor promotion and progressionR01CA118165 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KARIN, MICHAEL · 2007 to 2016
$4.6M
Microbiome and intestinal innate immune response in alcoholic liver diseaseR01AA020703 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHNABL, BERND G. · 2011 to 2020
$3.6M
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLDR01DK106419 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LOOMBA, ROHIT, SIRLIN, CLAUDE B · 2015 to 2019
$3.4M
Microbiome as Therapeutic Target in Alcoholic HepatitisU01AA021856 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BRENNER, DAVID A., SCHNABL, BERND G. · 2013 to 2017
$2.1M
The Role of the Intestinal Mycobiome in Alcoholic Liver DiseaseU01AA024726 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHNABL, BERND G. · 2017 to 2017
$353k
The Commensal Microflora Suppresses Liver FibrosisI01BX002213 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI SCHNABL, BERND G. · 2015 to 2018
–
NIAAA NIH HHS P50 AA011999NIEHS NIH HHS P42 ES010337
6 · The paper itself

Abstract

In the original version of Table 1 published online, upward arrows to indicate increased translocation of PAMPs were missing from the row entitled 'Translocation' for both the column on alcoholic liver disease and nonalcoholic fatty liver disease. This error has now been updated in the PDF and HTML version of the article.

Identifiers

PMID29785003
PMCPMC7133393

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.